hrcak mascot   Srce   HID

Pregledni rad


Klara Pulić
Sanja Klobučar Majanović

Puni tekst: hrvatski, pdf (376 KB) str. 0-0 preuzimanja: 1.312* citiraj
APA 6th Edition
Pulić, K. i Klobučar Majanović, S. (2017). ENDOKRINOLOŠKI ASPEKTI SINDROMA POLICISTIČNIH JAJNIKA. Liječnički vjesnik, 139 (9-10), 0-0. Preuzeto s
MLA 8th Edition
Pulić, Klara i Sanja Klobučar Majanović. "ENDOKRINOLOŠKI ASPEKTI SINDROMA POLICISTIČNIH JAJNIKA." Liječnički vjesnik, vol. 139, br. 9-10, 2017, str. 0-0. Citirano 17.05.2021.
Chicago 17th Edition
Pulić, Klara i Sanja Klobučar Majanović. "ENDOKRINOLOŠKI ASPEKTI SINDROMA POLICISTIČNIH JAJNIKA." Liječnički vjesnik 139, br. 9-10 (2017): 0-0.
Pulić, K., i Klobučar Majanović, S. (2017). 'ENDOKRINOLOŠKI ASPEKTI SINDROMA POLICISTIČNIH JAJNIKA', Liječnički vjesnik, 139(9-10), str. 0-0. Preuzeto s: (Datum pristupa: 17.05.2021.)
Pulić K, Klobučar Majanović S. ENDOKRINOLOŠKI ASPEKTI SINDROMA POLICISTIČNIH JAJNIKA. Liječnički vjesnik [Internet]. 2017 [pristupljeno 17.05.2021.];139(9-10):0-0. Dostupno na:
K. Pulić i S. Klobučar Majanović, "ENDOKRINOLOŠKI ASPEKTI SINDROMA POLICISTIČNIH JAJNIKA", Liječnički vjesnik, vol.139, br. 9-10, str. 0-0, 2017. [Online]. Dostupno na: [Citirano: 17.05.2021.]

Polycystic ovary syndrome, the most common endocrine disorder among women of reproductive age, is a result of interaction between ovarian genetic traits and many congenital and environmental factors. The most common postnatal contributor is obesity, but the fundamental disorder is in the intraovarian regulation of steroidogenesis, often accompanied by selective insulin resistance. The syndrome is clinically characterized by oligo-amenorrhea, menstrual dysfunction, infertility, hyperandrogenism, as well as the frequent presence of associated risk factors for cardiovascular disease and diabetes, including obesity, glucose intolerance and dyslipidemia. It is very important to identify and monitor the main features of metabolic syndrome and the risk for complications. Weight loss can restore ovulatory cycles and improve metabolic risk, so it is the first-line intervention for most women, but sometimes oral contraceptives and antiandrogens have to be added. In patients with insulin resistance and associated hyperinsulinemia insulin-sensitizing agents like metformin and thiazolidinediones have important role in its treatment.

Ključne riječi
Polycystic ovary syndrome – complications, etiology, physiopathology, therapy; Obesity – complications, metabolism; Hyperinsulinism – complications, physopathology; Insulin resistance; Hyperandrogenism – complications, physopathology; Ovary – physiopathology; Metabolic syndrome – etiology; Infertility, female – etiology; Cardiovascular diseases – etiology; Contraceptives, oral – therapeutic use; Metformin – therapeutic use; Thiazolidinediones – therapeutic use

Hrčak ID: 193283



Posjeta: 1.558 *